Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
2112-A THE PREDICTIVE SCORE FOR SCREENING METABOLIC ASSOCIATED FATTY LIVER DISEASE WITH SIGNIFICANT FIBROSIS IN THE PRIMARY CARE SETTING: A MULTICENTER STUDY Kessarin Thanapirom 1,2,3 , Kanokwan Sonsiri 1 , Panarat Thaimai 1 , Sirinporn Suksawatamnuay 1,2,3 , Piyawat Komolmit 1,2,3 and Sombat Treeprasertsuk 4 , (1)Division of Gastroenterology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand, (2)Center of Excellence in Liver Fibrosis and Cirrhosis, Chulalongkorn University, Bangkok, Thailand., (3)Excellence Center in Liver Diseases, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand, (4)Chulalongkorn University, Bangkok, Thailand Background: Identification of patients with metabolic associated fatty liver disease (MAFLD) at high risk for significant fibrosis (SF) in resource-limited settings remains challenging due to the inaccessibility of liver biopsy or liver elastography
She brings a strong clinical foundation paired with an energetic, knowledgeable, and approachable style that patients immediately connect with
) In this blog, Id like to explain why access to B12 shots as methylcobalamin is essential
W., Bowman, B
doi: 10.3389/fimmu.2025.1688761, 78
